The amplified enzyme-linked immunosorbent assay (amp-ELISA) was compared to the mouse bioassay for determination of botulinal neurotoxin types A, B, E, and F. Twelve different toxin-producing type A, 13 proteolytic type B, 9 nonproteolytic type B, 16 type E, 8 proteolytic type F, 5 nonproteolytic type F, and 6 nontoxigenic clostridial strains were tested. The cultures were inoculated into cooked meat medium (CMM) and tryptone-peptone-glucose-yeast extract (TPGY) medium, incubated for 5 days, and then examined for biological toxicity in mice and amp-ELISA endpoints. The amp-ELISA was less sensitive in detecting toxins produced by nonproteolytic than proteolytic strains of type B and F organisms. All of the toxin-producing strains tested were positive by the AOAC method and the amp-ELISA in either undiluted TPGY or CMM culture fluids regardless of mouse toxicity level, source, or strain. Cross-reactivity was observed between some but not all of the botulinal strains tested. None of the nontoxigenic strains were positive by the amp-ELISA. Purified botulinal toxins were also assayed using these 2 methods. The sensitivity of the amp-ELISA using purified neurotoxins was about 0.1 ng/mL for types A, B, and E and about 1.0 ng/mL for type F.
T he current U.S. Food and Drug Administration (FDA) procedure for determination of botulinal toxins is described in the AOAC's Official Methods of Analysis, 17th Ed. (1) . The method uses the mouse bioassay for Clostridium botulinum toxin detection, which is time-consuming and expensive, and requires animal housing facilities. Results require at least 3 days or as many as 6 days (discounting incubation of media) after analysis of suspect samples is initiated. The current method consists of a 3-part protocol: (1) in a screening assay, a limited number of sample dilutions are made and injected into mice and the animals are observed for 48 h; (2) if the mice die of botulism symptoms, the sample is diluted further, and injected until a dilution that does not kill mice is found; (3) after the end point is reached, the toxin type is determined by a toxin neutralization assay. At each phase of the analysis, the mice are observed for 48 h.
Faster analysis and detection of toxin(s) in suspected contaminated foods would allow the agency to respond more quickly to protect consumers. Enzyme-linked immunosorbent assay (ELISA) methods that are sensitive, specific, and rapid, providing 1-day results, have been devised for the detection of these toxins (2) (3) (4) (5) (6) . Bacteria are grown in media to develop toxin(s) that can be determined in the mouse bioassay and the ELISA procedures. The AOAC method also includes pure culture isolation and toxin typing of the isolates.
This study compares an ELISA procedure (7), which uses an amplified substrate (amp-ELISA), with the mouse bioassay for determination of types A, B, E, and F botulinal toxins from culture media. The amp-ELISA method could be used to screen culture media for botulinal toxins, with positive samples confirmed by the mouse bioassay.
Experimental

Study Design
A total of 63 botulinal toxin-producing clostridial strains were examined by the mouse bioassay and the amp-ELISA. The amp-ELISA was used to determine end points of toxins from Clostridium strains grown in tryptone-peptone-glucose-yeast extract (TPGY) and cooked meat medium (CMM), which are recommended in the AOAC method for botulinal toxin detection by the mouse bioassay (1). The mouse minimal lethal dose/mL of culture was determined only in TPGY, which usually yields more toxin than CMM. The media were inoculated from suspensions of spore stocks. Nonbotulinal strains that produce other toxins (C. perfingens, C. difficile, and C. tetani) were not injected into mice because some of them may have killed the mice nonspecifically. An amplified alkaline phosphatase substrate was used in the amp-ELISA for increased sensitivity over other substrates.
Sample Preparation
The AOAC method for determination of cultural botulinal toxins was followed. Tubes of CMM and TPGY media were inoculated with spore suspensions of the organisms and incubated for 5 days at 35 or 26°C, respectively. The culture media were then centrifuged at 10 000 × g for 10 min, the supernatant pH was adjusted to 6.2, and dilutions were made in gel-phosphate buffer before analysis by the mouse bioassay. Portions of the same culture media were also adjusted to pH 7.6, diluted 10-fold in casein buffer after centrifugation, and tested by the amp-ELISA. Nontoxigenic organisms were incubated for 5 days and examined with the amp-ELISA only. C. botulinum standard neurotoxin types A, B, and E, obtained from B.R. DasGupta (University of Wisconsin, Food Research Institute, Madison, WI), and type F neurotoxin from Mike Goodnough (University of Wisconsin, Madison, WI), were also examined by the mouse bioassay and the amp-ELISA.
Sample Analysis
Dilutions of purified toxins and cultures were tested for toxin by injecting pairs of mice intraperitoneally. Mice were observed for signs of botulism for 48 h, and the minimal lethal dose (MLD)/mL of culture was determined. The MLD was defined as the highest dilution of sample that killed both of the injected mice.
Microtiter plates coated with specific anti-botulinal toxin IgG types A, B, E, or F were used to capture toxins either from purified neurotoxins (Table 1) or cultures (Tables 2-6 ). The antitoxin stock solutions (Centers for Disease Control and Prevention [CDC], Atlanta, GA) were diluted in 0.05M bicarbonate buffer, pH 9.6, to concentrations of 0.5-2.0 µg/mL, and a 100 µL volume was added to each well of the microtiter plates. Biotinylated IgG antitoxins (CDC) were then allowed to bind to the captured toxins. Streptavidin conjugated to alkaline phosphatase (Sigma Chemical Co., St. Louis, MO) was reacted with these complexes, and the toxins were then indirectly detected with an amplified alkaline phosphatase substrate (GibCo, Grand Island, NY). The substrate was incu- bated for 12.5 min at room temperature with shaking (100 rpm), followed by a 3-10 min room temperature incubation with no shaking. The absorbance of the substrate was measured on a microplate reader set for 490 nm with 410 nm subtraction. A pink background developed as incubation time increased. The negative controls used included all reagents except toxin. A variety of positive controls were used, including toxin-producing cultures and purified neurotoxins. Specificity of the amp-ELISA was also examined by testing undiluted culture fluids for all 4 toxin types. The end point ELISA was the highest dilution of sample that yielded an absorbance 0.15 above the background absorbance.
Results and Discussion
Purified botulinal neurotoxins were detected at 0.1 ng/mL for types A, B, and E and at 1.0 ng/mL for type F (Table 1) . Sixty-three strains previously determined to produce botulinal toxin and 6 nontoxic clostridial strains, including C. subterminale, C. difficile, C. sporogenes, C. novyi, C. perfringens, and C. tetani, were tested by the amp-ELISA using undiluted and diluted culture media. The mouse bioassay and the amp-ELISA end points for the determination of toxins A, B, E, and F in culture supernatants were compared (Tables 2-5). All the botulinal toxigenic strains found positive by the mouse bioassay were also positive with the amp-ELISA. One type B and one type F strain were nontoxic by the mouse bioassay and the amp-ELISA. These nontoxic strains were viable anaerobic cultures that apparently lost their ability to produce toxin after original isolation and before receipt at our laboratory. The apparent lack of sensitivity for the amp-ELISA compared with the mouse bioassay is generally found at the end point of the toxic cultures. For example, culture No. 33A (Table 2 ) was diluted in 10-fold dilutions to a 10 -5 dilution, and each dilution was injected into 2 mice. At the 10 -5 dilution, both mice survived, whereas at the 10 -4 dilution, both mice died, indicating an MLD of 10 000/mL. The amp-ELISA was positive at the 10 -3 dilution but negative at 10 -4 . The apparent difference is about 10 MLD/mL sensitivity at the end points. In all the cultures examined, the amp-ELISA was positive at the lowest dilution tested. Nonbotulinal toxin-producing strains were negative with the amp-ELISA (Table 6) .
Cross-reactivity experiments (Table 7) were made for all the cultures. Some but not all of the strains cross-reacted with heterologous detection systems using undiluted culture supernatants. Why some of the strains (but not all) of a given toxin type cross-reacted with heterologous antitoxin types was not clarified. For a type A toxin-producer, the absorbance values obtained for cross-reacting strains were always lower with a heterologous detection antibody such as B, E, or F than with Table 4 . Minimal detectable levels of type E botulinal toxin/mL from culture media using the amp-ELlSA and the mouse bioassay the homologous detection. There is little cross-reactivity between purified neurotoxins at up to 100 ng toxin protein/mL concentration (about 5000 MLD/mL). Because the amp-ELISA test is a screening procedure for the presence of any of the 4 botulinal toxins, a toxin detected as 2 different types would still be confirmed with another approved test such as the mouse bioassay. The cultures were also examined by repeating the ELISA tests. Fresh media were inoculated, incubated for 5 days, and the ELISA end points were determined. This procedure was repeated 3 times. Differences in absorbance were observed on the different analysis dates. Absorbance values were usually within ±1 log of the original values. The mouse bioassay was not repeated for these tests, but variations in toxicity should also be expected for that assay. The data show that the amp-ELISA can be used to detect botulinal toxins from culture with sensitivity similar to that of the mouse bioassay. 
